Erratum in: Control of inflammation and prophylaxis of endophthalmitis after cataract surgery: A multicenter study, published in Eur J Ophthalmol 2007; 17: 733-42.
In the article: 'Control of inflammation and prophylaxis of endophthalmitis after cataract surgery: A multicenter study' by F.I. Camesasca, C. Bianchi, G. Beltrame, A. Caporossi, M. Piovella, A. Rapisarda, G. Tassinari, L. Zeppa, for the Italian Betamethasone-Chloramphenicol vs Dexamethasone-Tobramycin Combination Study Group, published in Eur J Ophthalmol 2007; 17: 733-42, on page 734, right column, last paragraph of the INTRODUCTION the word Carbomer has been omitted. We reprint herewith the correct paragraph: 'In this study we evaluated with a prospective, randomized clinical trial the efficacy of a chloramphenicol 0.25%-betamethasone 0.13% preparation in a gelified polyethyleneglycol 300-polyvinyl alcohol Carbomer carrier, administered three times a day, when compared to a tobramycin 3%-dexamethasone 1% in aqueous solution administered four times a day. Efficacy, frequency of complications, and patient satisfaction were studied''. On page 735, (right column, 19th line of the ''Study procedures'' paragraph) the product''s name was misprinted as well as the name of the Company. We reprint herewith the correct names: (Betabioptal gel, Farmila-Thea Farmaceutici, Milano, Italy). Moreover on pages 736 (Tabs III, IV), 737 (right column), 738 (Tab. VII), 739 (Tabs. VIII, IX) the products name is not Betagel but Betabioptal gel.